- Home
- HBB vs OABI Comparison
HBB vs OABI Comparison
Compare HBB & OABI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- HBB
- OABI
- Stock Information
- Founded
- HBB 1904
- OABI 2012
- Country
- HBB United States
- OABI United States
- Employees
- HBB N/A
- OABI N/A
- Industry
- HBB Home Furnishings
- OABI Biotechnology: Pharmaceutical Preparations
- Sector
- HBB Consumer Discretionary
- OABI Health Care
- Exchange
- HBB Nasdaq
- OABI Nasdaq
- Market Cap
- HBB 242.8M
- OABI 240.5M
- IPO Year
- HBB 2017
- OABI N/A
- Fundamental
- Price
- HBB $13.80
- OABI $2.02
- Analyst Decision
- HBB
- OABI Strong Buy
- Analyst Count
- HBB 0
- OABI 3
- Target Price
- HBB N/A
- OABI $6.67
- AVG Volume (30 Days)
- HBB 34.5K
- OABI 476.6K
- Earning Date
- HBB 07-30-2025
- OABI 08-06-2025
- Dividend Yield
- HBB 3.50%
- OABI N/A
- EPS Growth
- HBB N/A
- OABI N/A
- EPS
- HBB 2.35
- OABI N/A
- Revenue
- HBB $631,318,000.00
- OABI $23,027,000.00
- Revenue This Year
- HBB N/A
- OABI N/A
- Revenue Next Year
- HBB N/A
- OABI $45.02
- P/E Ratio
- HBB $5.59
- OABI N/A
- Revenue Growth
- HBB N/A
- OABI 6.05
- 52 Week Low
- HBB $12.72
- OABI $1.22
- 52 Week High
- HBB $31.78
- OABI $4.87
- Technical
- Relative Strength Index (RSI)
- HBB 39.31
- OABI 54.88
- Support Level
- HBB $12.72
- OABI $1.69
- Resistance Level
- HBB $14.90
- OABI $2.09
- Average True Range (ATR)
- HBB 1.08
- OABI 0.11
- MACD
- HBB -0.03
- OABI -0.00
- Stochastic Oscillator
- HBB 32.05
- OABI 82.72
About HBB Hamilton Beach Brands Holding Company
Hamilton Beach Brands Holding Co, through its subsidiaries, is engaged in consumer, commercial, and specialty small appliances and specialty retail. It designs, markets, and distributes small branded electric household and specialty housewares small appliances, as well as commercial products for restaurants, bars, and hotels. It has two operating segments Home and Commercial Products and Health.
About OABI OmniAb Inc.
OmniAb Inc offers therapeutic antibody discovery technologies. It focuses on enabling the rapid development of therapeutics by pushing the frontiers of drug discovery technologies. Its technology platform is designed to enable the efficient discovery of high-quality, fully human antibodies for a wide range of diseases. The heart of the OmniAb technology platform is the Biological Intelligence of its proprietary transgenic animals, including OmniRat, OmniMouse, and OmniChicken, that have been genetically modified to generate antibodies with human sequences which are naturally optimized through in vivo affinity maturation.